Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care
Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care
Status: Enrolling
Updated:  10/1/2015
mi
from
Madison, WI
Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care
Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
Status: Enrolling
Updated:  10/1/2015
mi
from
Madison, WI
Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)
Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)
Status: Enrolling
Updated:  10/1/2015
mi
from
Madison, WI
Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)
Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
mi
from
Los Angeles, CA
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
mi
from
Atlanta, GA
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
mi
from
Marietta, GA
Wellstar Kennestone Hospital
mi
from
Marietta, GA
Click here to add this to my saved trials
mi
from
Baltimore, MD
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
mi
from
Bethesda, MD
NIH Heart Center at Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
mi
from
Boston, MA
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
mi
from
Springfield, MA
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
mi
from
Bronx, NY
Montefiore Einstein Heart Center
mi
from
Bronx, NY
Click here to add this to my saved trials
mi
from
New York, NY
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
mi
from
Asheville, NC
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
mi
from
Durham, NC
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
mi
from
Greenville, NC
East Carolina Heart Institute
mi
from
Greenville, NC
Click here to add this to my saved trials
mi
from
Cleveland, OH
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
mi
from
Columbus, OH
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
mi
from
Philadelphia, PA
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
mi
from
Charlottesville, VA
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
mi
from
Falls Church, VA
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
mi
from
St Louis, MO
Washington University
mi
from
St Louis, MO
Click here to add this to my saved trials
mi
from
Plano, TX
Baylor Research Institute
mi
from
Plano, TX
Click here to add this to my saved trials
mi
from
Edmonton,
University of Alberta Hospital
mi
from
Edmonton,
Click here to add this to my saved trials
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  10/2/2015
mi
from
Atlanta, GA
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 10/2/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  10/2/2015
mi
from
Decatur, GA
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 10/2/2015
Atlanta VA Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  10/2/2015
mi
from
Bangor, ME
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 10/2/2015
Northeast Cardiology Associates
mi
from
Bangor, ME
Click here to add this to my saved trials
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  10/2/2015
mi
from
Palo Alto, CA
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 10/2/2015
VA Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  10/2/2015
mi
from
Stanford, CA
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 10/2/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  10/2/2015
mi
from
New Orleans, LA
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 10/2/2015
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  10/2/2015
mi
from
Aalst,
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 10/2/2015
OLV Ziekenhuis
mi
from
Aalst,
Click here to add this to my saved trials
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
A Phase 1/2, Open-Label, Dose-Escalation, Single Center, Clinical Study of MTP-131 (Ocuvia™) Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration.
Status: Enrolling
Updated:  10/2/2015
mi
from
Boston, MA
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
A Phase 1/2, Open-Label, Dose-Escalation, Single Center, Clinical Study of MTP-131 (Ocuvia™) Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration.
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
The Atlanta Cardiomyopathy Consortium
Status: Enrolling
Updated:  10/4/2015
mi
from
Atlanta, GA
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
The Atlanta Cardiomyopathy Consortium
Status: Enrolling
Updated: 10/4/2015
The Emory Clinic, Bldg A., 2nd Floor, 1365 Clifton Road, NE
mi
from
Atlanta, GA
Click here to add this to my saved trials
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
The Atlanta Cardiomyopathy Consortium
Status: Enrolling
Updated:  10/4/2015
mi
from
Atlanta, GA
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
The Atlanta Cardiomyopathy Consortium
Status: Enrolling
Updated: 10/4/2015
Center for Heart Failure at EUH Midtown, 4th Floor, 550 Peachtree Street
mi
from
Atlanta, GA
Click here to add this to my saved trials
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated:  10/5/2015
mi
from
Boston, MA
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated: 10/5/2015
Children's Hospital Boston - Harvard Medical School
mi
from
Boston, MA
Click here to add this to my saved trials
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated:  10/5/2015
mi
from
St. Louis, MO
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated: 10/5/2015
St. Louis Children's Hospital, Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated:  10/5/2015
mi
from
Bronx, NY
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated: 10/5/2015
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated:  10/5/2015
mi
from
New York, NY
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated: 10/5/2015
Children's Hospital of New York - Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated:  10/5/2015
mi
from
Philadelphia, PA
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated: 10/5/2015
The Children's Hospital of Philadelphia, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated:  10/5/2015
mi
from
Pittsburgh, PA
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated: 10/5/2015
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated:  10/5/2015
mi
from
Nashville, TN
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated: 10/5/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated:  10/5/2015
mi
from
Toronto,
Allo-Antibodies in Pediatric Heart Transplantation
Allo-Antibodies in Pediatric Heart Transplantation
Status: Enrolling
Updated: 10/5/2015
Hospital for Sick Children, Labatt Family Heart Centre
mi
from
Toronto,
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
Phoenix, AZ
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
Tuscon, AZ
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Tuscon, AZ
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
Little Rock, AR
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
Long Beach, CA
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
Torrance, CA
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
Aurora, CO
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
DeLand, FL
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
Pinellas Park, FL
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated:  10/5/2015
mi
from
Sarasota, FL
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials